92 related articles for article (PubMed ID: 1836021)
1. Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma.
Berná L; Germá JR; Estorch M; Torres G; Blanco R; Carrió I
J Nucl Med; 1991 Dec; 32(12):2295-8. PubMed ID: 1836021
[TBL] [Abstract][Full Text] [Related]
2. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
Duncker CM; Carrió I; Berná L; Estorch M; Alonso C; Ojeda B; Blanco R; Germá JR; Ortega V
J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer: a randomized study.
Jurincic CD; Horlbeck R; Klippel KF
Semin Oncol; 1991 Oct; 18(5 Suppl 6):21-5. PubMed ID: 1835139
[TBL] [Abstract][Full Text] [Related]
5. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G
Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
[TBL] [Abstract][Full Text] [Related]
6. A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
Lunglmayr G
Eur Urol; 1990; 18 Suppl 3():28-9. PubMed ID: 2151273
[No Abstract] [Full Text] [Related]
7. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
[TBL] [Abstract][Full Text] [Related]
8. 'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
Lunglmayr G
Prog Clin Biol Res; 1989; 303():145-51. PubMed ID: 2528737
[TBL] [Abstract][Full Text] [Related]
9. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
Rudberg U; Udén R; Ahlbäck SO
Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
[TBL] [Abstract][Full Text] [Related]
10. Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group.
Carvalho AP; de Moura JL; Denis L; Newling D; Smith P; Bono A; Sylvester R; De Pauw M; Ongena P
Prog Clin Biol Res; 1989; 303():129-43. PubMed ID: 2528736
[No Abstract] [Full Text] [Related]
11. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
Berná L; Torres G; Carrió I; Estorch M; Germá JR; Alonso C
Clin Nucl Med; 1994 Feb; 19(2):121-8. PubMed ID: 8187396
[TBL] [Abstract][Full Text] [Related]
12. LHRH analogues in combination with an anti-androgen in the treatment of advanced disease.
Denis L
Horm Res; 1989; 32 Suppl 1():66-7; discussion 68. PubMed ID: 2533158
[TBL] [Abstract][Full Text] [Related]
13. Complete androgen blockade: data from an EORTC 30853 trial.
Denis L; Keuppens F; Robinson M; Mahler C; Smith P; Pinto de Carvalho AP; Newling D; Bono A; Sylvester R; De Pauw M
Semin Urol; 1990 Aug; 8(3):166-74. PubMed ID: 2144656
[No Abstract] [Full Text] [Related]
14. LHRH-analogues therapy for metastatic prostate cancer.
Debruyne FM; Fernandez del Moral P; Geboers AD
Prog Clin Biol Res; 1988; 260():27-39. PubMed ID: 2966406
[No Abstract] [Full Text] [Related]
15. [Osteoplastic bone metastases in prostatic carcinoma: magnetic resonance tomography and bone marrow scintigraphy].
Venz S; Hosten N; Friedrichs R; Neumann K; Cordes M; Nagel R; Felix R
Rofo; 1994 Jul; 161(1):64-9. PubMed ID: 8043767
[TBL] [Abstract][Full Text] [Related]
16. [How can a nursing team participate in a clinical trial? Zoladex, flutamide trial].
Guidez C
Soins; 1990 Sep; (540):53. PubMed ID: 2151069
[No Abstract] [Full Text] [Related]
17. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
Bathmann J; Moser E
Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
[TBL] [Abstract][Full Text] [Related]
18. [Orchiectomy and buserelin in combination with flutamide: comparative results in metastatic prostatic carcinoma].
Mora MJ; Extramiana J; Paniagua P; González P; Mañas A; Pérez MJ; Navarro J; Arrizabalaga M
Actas Urol Esp; 1991; 15(6):548-52. PubMed ID: 1792994
[TBL] [Abstract][Full Text] [Related]
19. Total androgen ablation: European experience. The EORTC GU Group.
Denis L; Smith P; Carneiro de Moura JL; Newling D; Bono A; Keuppens F; Mahler C; Robinson M; Sylvester R; De Pauw M
Urol Clin North Am; 1991 Feb; 18(1):65-73. PubMed ID: 1825144
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
